整合放射学,病理学和活检适应免疫评分,用于预测局部晚期直肠癌的远程转移

R Zhao1, W Shen2, W Zhao3

  • 1Departments of Diagnositic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ESMO open
|February 14, 2025
PubMed
概括

一种新型的诺米图准确地预测了接受新辅助化疗或放射治疗 (nCRT) 的局部晚期直肠癌 (LARC) 患者的远程转移. 它整合了放射学,病理学和活检适应的免疫评分 (ISB) 进行有效的风险分层.